Citadel Advisors - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$8,605,741
-38.8%
654,927
-41.3%
0.00%
-33.3%
Q2 2023$14,055,313
+10.8%
1,115,501
+14.7%
0.00%0.0%
Q1 2023$12,689,964
-26.0%
972,411
+0.1%
0.00%
-25.0%
Q4 2022$17,138,072
-24.0%
971,546
-34.4%
0.00%
-20.0%
Q3 2022$22,553,000
+131.3%
1,480,863
+125.2%
0.01%
+66.7%
Q2 2022$9,751,000
-77.2%
657,518
-65.3%
0.00%
-66.7%
Q1 2022$42,709,000
+418.1%
1,896,461
+324.4%
0.01%
+350.0%
Q4 2021$8,244,000
+300.2%
446,835
+190.1%
0.00%
Q3 2021$2,060,000
-37.8%
154,046
-13.9%
0.00%
Q2 2021$3,310,000
-43.5%
178,822
-54.2%
0.00%
-100.0%
Q1 2021$5,858,000
+166.8%
390,126
+156.5%
0.00%
Q4 2020$2,196,000
+111.2%
152,079
+19.1%
0.00%
Q3 2020$1,040,000
-68.4%
127,740
-73.7%
0.00%
-100.0%
Q2 2020$3,289,000
-36.0%
485,808
-33.5%
0.00%
-50.0%
Q1 2020$5,143,000
+189.9%
730,507
+304.3%
0.00%
+100.0%
Q4 2019$1,774,000
+51.4%
180,695
+69.3%
0.00%
Q3 2019$1,172,000
+4.3%
106,747
+10.4%
0.00%
Q2 2019$1,124,000
-53.7%
96,680
-62.0%
0.00%
-100.0%
Q1 2019$2,426,000
+287.5%
254,259
+291.6%
0.00%
Q4 2018$626,000
-86.6%
64,933
-80.2%
0.00%
-100.0%
Q3 2018$4,665,000
+84.0%
327,293
+55.0%
0.00%
+100.0%
Q2 2018$2,535,000
-34.8%
211,136
-33.0%
0.00%
-50.0%
Q1 2018$3,891,000
-59.4%
315,065
-52.2%
0.00%
-66.7%
Q4 2017$9,591,000
-21.0%
659,131
-22.7%
0.01%
-33.3%
Q3 2017$12,140,000
-22.2%
853,129
-30.2%
0.01%
-30.8%
Q2 2017$15,598,000
-37.3%
1,222,341
-37.7%
0.01%
-40.9%
Q1 2017$24,872,000
+2205.1%
1,961,443
+1755.4%
0.02%
+2100.0%
Q4 2016$1,079,000
+190.8%
105,715
+274.9%
0.00%
Q3 2016$371,000
-88.9%
28,200
-88.9%
0.00%
-100.0%
Q1 2016$3,355,000
+6610.0%
253,977
+6208.4%
0.00%
Q3 2015$50,000
-99.8%
4,026
-99.8%
0.00%
-100.0%
Q2 2015$29,419,000
-21.4%
2,150,484
-31.3%
0.03%
-25.7%
Q1 2015$37,431,000
+79.7%
3,129,646
+91.8%
0.04%
+75.0%
Q4 2014$20,832,000
+325.2%
1,631,365
+346.7%
0.02%
+300.0%
Q3 2014$4,899,000
+1165.9%
365,189
+1414.3%
0.01%
Q2 2014$387,000
-20.5%
24,116
-10.6%
0.00%
-100.0%
Q1 2014$487,000
+107.2%
26,989
+77.4%
0.00%
Q4 2013$235,000
+351.9%
15,214
+279.3%
0.00%
Q2 2013$52,0004,0110.00%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q1 2022
NameSharesValueWeighting ↓
Tamarack Advisers, LP 875,000$13,138,0002.70%
KESTREL INVESTMENT MANAGEMENT CORP 417,400$6,267,0002.63%
SHAPIRO CAPITAL MANAGEMENT LLC 16,933,530$127,255,604,0002.31%
Adirondack Research & Management Inc. 123,148$1,849,0002.19%
Smith, Graham & Co., Investment Advisors, LP 966,216$14,508,0001.18%
Lombard Odier Asset Management (Switzerland) SA 839,521$12,605,0000.84%
HENNESSY ADVISORS INC 946,800$14,216,0000.83%
Waterfront Wealth Inc. 95,403$1,464,0000.74%
Arjuna Capital 84,697$1,272,0000.62%
SummerHaven Investment Management, LLC 62,844$944,0000.58%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders